Bank of New York Mellon »

Apellis Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.9M 344k 28.84
2024-06-30 $13M 345k 38.36
2024-03-31 $19M 323k 58.78
2023-12-31 $22M 372k 59.86
2023-09-30 $14M 360k 38.04
2023-06-30 $33M 357k 91.10
2023-03-31 $26M 392k 65.96
2022-12-31 $21M 405k 51.71
2022-09-30 $28M 409k 68.04
2022-06-30 $16M 348k 45.22
2022-03-31 $16M 316k 50.81
2021-12-31 $14M 298k 46.51
2021-09-30 $8.9M 270k 32.96
2021-06-30 $17M 262k 63.20
2021-03-31 $9.7M 227k 42.91
2020-12-31 $15M 254k 57.20
2020-09-30 $7.2M 238k 30.17
2020-06-30 $0 244k 0.00
2020-03-31 $6.4M 240k 26.79
2019-12-31 $6.0M 196k 30.62
2019-09-30 $4.6M 190k 24.09
2019-06-30 $5.1M 200k 25.34
2019-03-31 $3.3M 170k 19.50
2018-12-31 $2.0M 153k 13.20
2018-09-30 $2.5M 143k 17.78
2018-06-30 $2.8M 127k 22.01
2018-03-31 $771k 35k 22.10
2017-12-31 $415k 19k 21.65